These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 25750536)

  • 1. Role of physiotherapy and patient education in lymphedema control following breast cancer surgery.
    Lu SR; Hong RB; Chou W; Hsiao PC
    Ther Clin Risk Manag; 2015; 11():319-27. PubMed ID: 25750536
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The incidence and risk factors of related lymphedema for breast cancer survivors post-operation: a 2-year follow-up prospective cohort study.
    Zou L; Liu FH; Shen PP; Hu Y; Liu XQ; Xu YY; Pen QL; Wang B; Zhu YQ; Tian Y
    Breast Cancer; 2018 May; 25(3):309-314. PubMed ID: 29397555
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Breast Cancer-Related Lymphedema Risk is Related to Multidisciplinary Treatment and Not Surgery Alone: Results from a Large Cohort Study.
    Nguyen TT; Hoskin TL; Habermann EB; Cheville AL; Boughey JC
    Ann Surg Oncol; 2017 Oct; 24(10):2972-2980. PubMed ID: 28766228
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Utilization of bioimpedance spectroscopy in the prevention of chronic breast cancer-related lymphedema.
    Kaufman DI; Shah C; Vicini FA; Rizzi M
    Breast Cancer Res Treat; 2017 Dec; 166(3):809-815. PubMed ID: 28831632
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk of breast cancer recurrence in patients receiving manual lymphatic drainage: a hospital-based cohort study.
    Hsiao PC; Liu JT; Lin CL; Chou W; Lu SR
    Ther Clin Risk Manag; 2015; 11():349-58. PubMed ID: 25767390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Utilization of bioelectrical impedance analysis for detection of lymphedema in breast Cancer survivors: a prospective cross sectional study.
    Lim SM; Han Y; Kim SI; Park HS
    BMC Cancer; 2019 Jul; 19(1):669. PubMed ID: 31286884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reducing Breast Cancer-Related Lymphedema (BCRL) Through Prospective Surveillance Monitoring Using Bioimpedance Spectroscopy (BIS) and Patient Directed Self-Interventions.
    Kilgore LJ; Korentager SS; Hangge AN; Amin AL; Balanoff CR; Larson KE; Mitchell MP; Chen JG; Burgen E; Khan QJ; O'Dea AP; Nye L; Sharma P; Wagner JL
    Ann Surg Oncol; 2018 Oct; 25(10):2948-2952. PubMed ID: 29987599
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adjuvant taxanes and the development of breast cancer-related arm lymphoedema.
    Cariati M; Bains SK; Grootendorst MR; Suyoi A; Peters AM; Mortimer P; Ellis P; Harries M; Van Hemelrijck M; Purushotham AD
    Br J Surg; 2015 Aug; 102(9):1071-8. PubMed ID: 26040263
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early Disturbance of Lymphatic Transport as a Risk Factor for the Development of Breast-Cancer-Related Lymphedema.
    Thomis S; Devoogdt N; Bechter-Hugl B; Fourneau I
    Cancers (Basel); 2023 Mar; 15(6):. PubMed ID: 36980660
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lymphovascular invasion and extranodal tumour extension are risk indicators of breast cancer related lymphoedema: an observational retrospective study with long-term follow-up.
    Invernizzi M; Corti C; Lopez G; Michelotti A; Despini L; Gambini D; Lorenzini D; Guerini-Rocco E; Maggi S; Noale M; Fusco N
    BMC Cancer; 2018 Sep; 18(1):935. PubMed ID: 30268112
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frequency and risk factors for arm lymphedema after multimodal breast-conserving treatment of nodal positive breast Cancer - a long-term observation.
    Rupp J; Hadamitzky C; Henkenberens C; Christiansen H; Steinmann D; Bruns F
    Radiat Oncol; 2019 Mar; 14(1):39. PubMed ID: 30845971
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A retrospective analysis of commonly prescribed medications and the risk of developing breast cancer related lymphedema.
    Meijer EF; Bouta EM; Mendonca C; Skolny MN; Salama LW; Taghian AG; Padera TP
    Clin Res Trials; 2020 Feb; 6(1):. PubMed ID: 32864167
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk factors for lymphedema in a prospective breast cancer survivorship study: the Pathways Study.
    Kwan ML; Darbinian J; Schmitz KH; Citron R; Partee P; Kutner SE; Kushi LH
    Arch Surg; 2010 Nov; 145(11):1055-63. PubMed ID: 21079093
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lymph node status and breast cancer-related lymphedema.
    Purushotham AD; Bennett Britton TM; Klevesath MB; Chou P; Agbaje OF; Duffy SW
    Ann Surg; 2007 Jul; 246(1):42-5. PubMed ID: 17592289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of providing information about lymphedema on the cognitive and symptom outcomes of breast cancer survivors.
    Fu MR; Chen CM; Haber J; Guth AA; Axelrod D
    Ann Surg Oncol; 2010 Jul; 17(7):1847-53. PubMed ID: 20140528
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Breast cancer-related lymphedema: women's experiences with an underestimated condition.
    Thomas-MacLean R; Miedema B; Tatemichi SR
    Can Fam Physician; 2005 Feb; 51(2):246-7. PubMed ID: 16926934
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lymphedema in Inflammatory Breast Cancer Patients Following Trimodal Treatment.
    Farley CR; Irwin S; Adesoye T; Sun SX; DeSnyder SM; Lucci A; Shaitelman SF; Chang EI; Ueno NT; Woodward WA; Teshome M
    Ann Surg Oncol; 2022 Oct; 29(10):6370-6378. PubMed ID: 35854031
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors associated with the development of breast cancer-related lymphedema after whole-breast irradiation.
    Shah C; Wilkinson JB; Baschnagel A; Ghilezan M; Riutta J; Dekhne N; Balaraman S; Mitchell C; Wallace M; Vicini F
    Int J Radiat Oncol Biol Phys; 2012 Jul; 83(4):1095-100. PubMed ID: 22099041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Breast Cancer Systemic Treatments and Upper Limb Lymphedema: A Risk-Assessment Platform Encompassing Tumor-Specific Pathological Features Reveals the Potential Role of Trastuzumab.
    Invernizzi M; Michelotti A; Noale M; Lopez G; Runza L; Giroda M; Despini L; Blundo C; Maggi S; Gambini D; Fusco N
    J Clin Med; 2019 Jan; 8(2):. PubMed ID: 30682851
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Body Mass Index as a Major Risk Factor for Severe Breast Cancer-Related Lymphedema.
    Leray H; Malloizel-Delaunay J; Lusque A; Chantalat E; Bouglon L; Chollet C; Chaput B; Garmy-Susini B; Yannoutsos A; Vaysse C
    Lymphat Res Biol; 2020 Dec; 18(6):510-516. PubMed ID: 32283042
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.